Page last updated: 2024-08-21

erythromycin and warfarin

erythromycin has been researched along with warfarin in 56 studies

Research

Studies (56)

TimeframeStudies, this research(%)All Research%
pre-199022 (39.29)18.7374
1990's7 (12.50)18.2507
2000's13 (23.21)29.6817
2010's14 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jolivette, LJ; Ward, KW1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Fent, K; Popovic, M; Smital, T; Zaja, R1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Adebesin, AM; Falck, JR; Fischer, R; Konkel, A; Lossie, J; Paudyal, MP; Puli, N; Schunck, WH; Vijaykumar, J; Wesser, T; Westphal, C; Zhu, C1
Warkany, J1
Brenner, S; Elman, M; Wolf, R1
Hardesty, B; Ma, CH; Picking, WD; Picking, WL1
Cook, CE; Jagger, PI; Klauber, MR; Lorentz, SM; Townsend, RJ; Weibert, RT1
Raasch, RH1
Baciewicz, AM1
Golbus, MS; Goldberg, JD1
Nguyen, P; Pibouin, M; Renouard, A; Tillement, JP; Zini, R1
Bachmann, K1
Dibb, WL; Digranes, A; Salveson, A1
Altman, H; Howrie, DL; Maroon, TJ; Zitelli, BJ1
Hassell, D; Utt, JK1
Boyle, DA; Bussey, HI; Knodel, LC1
Fossati, C1
Jackson, RA; Smith, MC1
Bachmann, KA; Schwartz, JI1
Brown, SE; Gray, DR; Sato, RI1
Bachmann, K; Perrigo, E; Schwartz, J1
Husserl, FE1
Bachmann, K; Forney, R; Frogameni, A; Jauregui, LE; Schwartz, JI1
D'Arcy, PF1
Bartle, WR1
Barre, J; Campos, H; d'Athis, P; Prandota, J; Tillement, JP1
Buters, JT; Friedman, FK; Koley, AP; Markowitz, A; Robinson, RC1
Deeble, T; Wood, GD1
Inoue, K; Mimura, M; Nakamura, S; Oda, H; Ohmori, S; Shimada, T; Yamazaki, H1
Ariyaratnam, S; Pemberton, M; Sloan, P; Thakker, NS; Thornhill, MH1
Hirayama, F; Iizumi, Y; Kawasaki, T; Koshio, H; Matsumoto, Y; Sato, K; Taniuchi, Y1
Gómez-López, T; Martínez-Quintas, MJ; Sanz, E1
Fowler, SM; Friedberg, T; Riley, RJ; Taylor, JM; Wolf, CR1
AMSTUTZ, P; BAROIS, A; GORCE, F; GOULON, M; RAPIN, M1
Fuhr, U; Kober, S; Mutschler, E; Spahn-Langguth, H; Zaigler, M1
Kreander, K; Tammela, P; Vuorela, P1
Chaudhary, A; Drijfhout, WJ; Garner, RC; Jochemsen, R; Kneer, J; Kuhnz, W; Lappin, G; Oosterhuis, B; Rowland, M1
Gerschutz, GP; Hoffmann, TK; Malone, PM; Parker, DL; Tucker, MA1
Horn, JR1

Reviews

4 review(s) available for erythromycin and warfarin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Sulfonamide-induced bullous hemorrhagic eruption in a patient with low prothrombin time.
    Israel journal of medical sciences, 1992, Volume: 28, Issue:12

    Topics: Biopsy; Drug Eruptions; Drug Interactions; Eosinophils; Erythromycin; Female; Fluocortolone; Hematoma; Humans; Leukocytes, Mononuclear; Middle Aged; Mitral Valve Insufficiency; Neutrophils; Prothrombin Time; Respiratory Tract Infections; Skin Diseases, Vesiculobullous; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin

1992
Carbamazepine drug interactions.
    Therapeutic drug monitoring, 1986, Volume: 8, Issue:3

    Topics: Carbamazepine; Cimetidine; Dextropropoxyphene; Drug Interactions; Erythromycin; Humans; Isoniazid; Lithium; Phenobarbital; Phenytoin; Primidone; Protein Binding; Troleandomycin; Valproic Acid; Warfarin

1986
[Liver damage due to drugs. I].
    La Clinica terapeutica, 1974, Jan-15, Volume: 68, Issue:1

    Topics: Arsenicals; Chemical and Drug Induced Liver Injury; Chloramphenicol; Cholestasis; Coumarins; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Halothane; Humans; Imipramine; Liver; Methotrexate; Methyldopa; Nicotinic Acids; Oxacillin; Phenylbutazone; Testosterone; Tetracycline

1974

Trials

1 trial(s) available for erythromycin and warfarin

ArticleYear
Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Area Under Curve; Carbon Radioisotopes; Chromatography, Liquid; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Drug Monitoring; Erythromycin; Estradiol; Female; GABA Modulators; Humans; Injections, Intravenous; Male; Mass Spectrometry; Midazolam; Middle Aged; Warfarin

2006

Other Studies

51 other study(ies) available for erythromycin and warfarin

ArticleYear
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7

    Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
    Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19

    Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7

    Topics: Glutathione; Pharmacology; Sulfur Radioisotopes

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.
    The Journal of biological chemistry, 2013, Nov-22, Volume: 288, Issue:47

    Topics: Animals; Evolution, Molecular; Glycosylation; Gonadal Steroid Hormones; HEK293 Cells; Humans; Ion Transport; Organic Anion Transporters; Protein Multimerization; Zebrafish; Zebrafish Proteins

2013
Development of Robust 17(
    Journal of medicinal chemistry, 2019, 11-27, Volume: 62, Issue:22

    Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arachidonic Acids; Dose-Response Relationship, Drug; Drug Stability; Epoxide Hydrolases; Esterification; Hepatocytes; Humans; Male; Mice; Microsomes, Liver; Myocardial Infarction; Myocytes, Cardiac; Rats, Sprague-Dawley; Rats, Wistar

2019
A warfarin embryopathy?
    American journal of diseases of children (1960), 1975, Volume: 129, Issue:3

    Topics: Abnormalities, Drug-Induced; Alcoholism; Chondrodysplasia Punctata; Diazepam; Digitalis Glycosides; Erythromycin; Female; Fetus; Heart Valve Prosthesis; Heparin; Humans; Infant, Newborn; Penicillin G Benzathine; Pregnancy; Pregnancy Complications; Sulfisoxazole; Syphilis; Thrombosis; Warfarin

1975
A synthetic alanyl-initiator tRNA with initiator tRNA properties as determined by fluorescence measurements: comparison to a synthetic alanyl-elongator tRNA.
    Nucleic acids research, 1991, Oct-25, Volume: 19, Issue:20

    Topics: Base Sequence; Coumarins; Erythromycin; Kinetics; Molecular Sequence Data; Nucleic Acid Conformation; Peptide Chain Elongation, Translational; Peptide Chain Initiation, Translational; Peptide Initiation Factors; Poly U; Prokaryotic Initiation Factor-2; Protein Biosynthesis; Puromycin; Ribosomes; RNA, Transfer, Ala; RNA, Transfer, Met; Sparsomycin; Spectrometry, Fluorescence

1991
Effect of erythromycin in patients receiving long-term warfarin therapy.
    Clinical pharmacy, 1989, Volume: 8, Issue:3

    Topics: Adult; Aged; Drug Interactions; Erythromycin; Female; Humans; Male; Middle Aged; Prothrombin; Prothrombin Time; Radioimmunoassay; Stereoisomerism; Warfarin

1989
Interactions of oral antibiotics and common chronic medications.
    Geriatrics, 1987, Volume: 42, Issue:1

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Allopurinol; Ampicillin; Antacids; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Digoxin; Drug Combinations; Drug Interactions; Erythromycin; Humans; Sulfamethoxazole; Sulfonamides; Sulfonylurea Compounds; Tetracycline; Theophylline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin

1987
The value of case reports in human teratology.
    American journal of obstetrics and gynecology, 1986, Volume: 154, Issue:3

    Topics: Abnormalities, Drug-Induced; Animals; Antiemetics; Dicyclomine; Doxylamine; Drug Combinations; Erythromycin; Female; Humans; Infant, Newborn; Isotretinoin; Medical Records; Pregnancy; Publishing; Pyridoxine; Teratogens; Thalidomide; Tretinoin; Warfarin

1986
Binding of 8-methoxypsoralen to human serum proteins and red blood cells.
    The British journal of dermatology, 1987, Volume: 117, Issue:2

    Topics: Binding Sites; Blister; Blood Proteins; Diazepam; Erythrocytes; Erythromycin; Humans; Indomethacin; Methoxsalen; Protein Binding; Salicylates; Salicylic Acid; Warfarin

1987
Screening for the influence of host factors on warfarin clearance using a single dose single sample procedure.
    International journal of clinical pharmacology, therapy, and toxicology, 1986, Volume: 24, Issue:4

    Topics: Adult; Drug Interactions; Erythromycin; Humans; Kinetics; Liver; Male; Metabolic Clearance Rate; Warfarin

1986
Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents.
    Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology, 1986, Volume: 94, Issue:2

    Topics: Aminocoumarins; Ampicillin; Anti-Bacterial Agents; Clindamycin; Cloxacillin; Coumarins; Doxycycline; Erythromycin; Gram-Positive Bacteria; Humans; Netilmicin; Penicillin G; Staphylococcus; Streptococcus; Vancomycin

1986
Erythromycin-induced drug interactions. An illustrative case and review of the literature.
    Clinical pediatrics, 1987, Volume: 26, Issue:3

    Topics: Carbamazepine; Child; Cyclosporins; Digoxin; Drug Interactions; Erythromycin; Female; Humans; Metabolic Clearance Rate; Theophylline; Warfarin

1987
Suspected interaction: warfarin and erythromycin.
    Southern medical journal, 1985, Volume: 78, Issue:8

    Topics: Adult; Drug Interactions; Erythromycin; Humans; Male; Recurrence; Thrombophlebitis; Warfarin

1985
Warfarin-erythromycin interaction.
    Archives of internal medicine, 1985, Volume: 145, Issue:9

    Topics: Drug Interactions; Erythromycin; Humans; Warfarin

1985
Relations between price and quality in community pharmacy.
    Medical care, 1974, Volume: 12, Issue:1

    Topics: Aspirin; Community Pharmacy Services; Contraceptives, Oral; Drug Interactions; Drug Prescriptions; Erythromycin; Fees, Pharmaceutical; Health Education; Mississippi; Pharmacists; Quality of Health Care; Thermometers; Warfarin

1974
Erythromycin-warfarin interaction.
    Archives of internal medicine, 1984, Volume: 144, Issue:10

    Topics: Drug Interactions; Erythromycin; Humans; Male; Warfarin

1984
Warfarin interaction with erythromycin.
    Archives of internal medicine, 1984, Volume: 144, Issue:12

    Topics: Drug Interactions; Erythromycin; Hemoptysis; Humans; Legionnaires' Disease; Male; Middle Aged; Warfarin

1984
Interaction between warfarin and erythromycin.
    Southern medical journal, 1983, Volume: 76, Issue:1

    Topics: Animals; Drug Interactions; Embolism; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Male; Middle Aged; Parotitis; Partial Thromboplastin Time; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors; Warfarin

1983
Erythromycin-warfarin interaction.
    Archives of internal medicine, 1983, Volume: 143, Issue:9

    Topics: Aged; Drug Synergism; Erythromycin; Humans; Male; Warfarin

1983
The effect of erythromycin on the disposition kinetics of warfarin.
    Pharmacology, 1984, Volume: 28, Issue:3

    Topics: Adult; Drug Interactions; Erythromycin; Humans; Kinetics; Male; Metabolic Clearance Rate; Warfarin

1984
Early reports on drug interactions.
    Drug intelligence & clinical pharmacy, 1983, Volume: 17, Issue:2

    Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine

1983
Possible warfarin-erythromycin interaction.
    Archives of internal medicine, 1980, Volume: 140, Issue:7

    Topics: Aged; Drug Synergism; Erythromycin; Female; Humans; Warfarin

1980
Binding of erythromycin base to human plasma proteins.
    The Journal of international medical research, 1980, Volume: 8 Suppl 2

    Topics: Aspirin; Bilirubin; Blood Proteins; Erythromycin; Furosemide; Humans; Hydrogen-Ion Concentration; Orosomucoid; Phenylbutazone; Protein Binding; Serum Albumin; Temperature; Warfarin

1980
CO binding kinetics of human cytochrome P450 3A4. Specific interaction of substrates with kinetically distinguishable conformers.
    The Journal of biological chemistry, 1995, Mar-10, Volume: 270, Issue:10

    Topics: Animals; Carbon Monoxide; Cimetidine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Ethinyl Estradiol; Humans; Kinetics; Mixed Function Oxygenases; Nifedipine; Protein Binding; Quinidine; Recombinant Proteins; Spodoptera; Substrate Specificity; Testosterone; Time Factors; Transfection; Warfarin

1995
Warfarin: dangers with antibiotics.
    Dental update, 1993, Volume: 20, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acids; Dental Care for Chronically Ill; Drug Interactions; Erythromycin; Female; Humans; Male; Middle Aged; Warfarin

1993
Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
    Archives of toxicology, 1997, Volume: 71, Issue:6

    Topics: Adrenergic beta-Antagonists; Aniline Compounds; Animals; Antineoplastic Agents; Benzphetamine; Carcinogens; Coumarins; Cytochrome P-450 Enzyme System; Dogs; Erythromycin; Ethanolamines; Ethylmorphine; Guinea Pigs; Humans; Macaca fascicularis; Mephenytoin; Microsomes, Liver; Nifedipine; Oxazines; Oxidation-Reduction; Phenacetin; Phenytoin; Rats; Species Specificity

1997
Treating oral candidiasis: potentially fatal.
    British dental journal, 1997, Aug-09, Volume: 183, Issue:3

    Topics: Anti-Bacterial Agents; Anticoagulants; Antifungal Agents; Candidiasis, Oral; Drug Interactions; Erythromycin; Fluconazole; Humans; Warfarin

1997
Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.
    Japanese journal of pharmacology, 1998, Volume: 78, Issue:2

    Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Antifibrinolytic Agents; Blood Coagulation; Carbamazepine; Cimetidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Male; Mice; Mice, Inbred ICR; Partial Thromboplastin Time; Phenytoin; Piperidines; Prothrombin Time; Rifampin; Sulfonamides; Thromboembolism; Thromboplastin; Vitamin K 1; Warfarin

1998
Perception of teratogenic risk of common medicines.
    European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 95, Issue:1

    Topics: Abnormalities, Drug-Induced; Chi-Square Distribution; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Health Knowledge, Attitudes, Practice; Humans; Physicians; Pregnancy; Risk Factors; Students, Medical; Teratogens; Warfarin

2001
CYP3A4 active site volume modification by mutagenesis of leucine 211.
    Drug metabolism and disposition: the biological fate of chemicals, 2002, Volume: 30, Issue:4

    Topics: Amino Acid Substitution; Anti-Anxiety Agents; Anti-Bacterial Agents; Binding Sites; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diazepam; Enzyme Activation; Enzyme Inhibitors; Erythromycin; Hydroxylation; Kinetics; Leucine; Mixed Function Oxygenases; Mutagenesis, Site-Directed; Oxidation-Reduction; Structure-Activity Relationship; Substrate Specificity; Testosterone; Troleandomycin

2002
[ANURIA CAUSED BY ACUTE INTERSTITIAL NEPHROPATHY IN THE COURSE OF PROLONGED PHENINDIONE TREATMENT].
    La Presse medicale, 1964, Sep-23, Volume: 72

    Topics: Anuria; Chloramphenicol; Coma; Coumarins; Dermatitis; Diagnosis; Dialysis; Eosinophils; Erythromycin; Fever; Isoniazid; Methicillin; Nephritis; Nephritis, Interstitial; Pathology; Penicillins; Peritoneal Cavity; Phenindione; Renal Dialysis; Streptomycin; Toxicology

1964
Rate-limiting biotransformation of triamterene is mediated by CYP1A2.
    International journal of clinical pharmacology and therapeutics, 2005, Volume: 43, Issue:7

    Topics: Caffeine; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythromycin; Humans; Hydroxylation; Ketoconazole; Kinetics; Microsomes, Liver; Omeprazole; Quinidine; Substrate Specificity; Sulfuric Acid Esters; Theophylline; Triamterene

2005
A rapid screening method for detecting active compounds against erythromycin-resistant bacterial strains of Finnish origin.
    Folia microbiologica, 2005, Volume: 50, Issue:6

    Topics: Anti-Bacterial Agents; Coumarins; Drug Resistance, Bacterial; Erythromycin; Finland; Flavonoids; Gallic Acid; Humans; Hydroxybenzoates; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Penicillin G; Staphylococcus; Streptococcus pyogenes; Time Factors

2005
Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Jan-01, Volume: 67, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Drug Synergism; Erythromycin; Female; Humans; International Normalized Ratio; Ophthalmic Solutions; Warfarin

2010
Analysis of purported erythromycin-warfarin interaction.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Jun-15, Volume: 67, Issue:12

    Topics: Anti-Bacterial Agents; Anticoagulants; Drug Interactions; Erythromycin; Humans; Liver; Ointments; Ophthalmic Solutions; Warfarin

2010